TrialInternational clinical psychopharmacology2014

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study.

Stuart A Montgomery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.